Akoya Biosciences $151.3 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Recursion Pharmaceuticals $500 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Vale R$11.5 billion participating debentures
We advised the placement agents on the offering
Americo Life $400 million senior notes offering
We advised the initial purchasers on the investment-grade notes offering
Maravai LifeSciences $646.9 million secondary offering
We advised the joint book-running managers on the equity offering
Marvell Technology $2 billion senior notes offering
We advised the initial purchasers on the unregistered debt offering
Frontier $655.5 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Boston Omaha $66.1 million follow-on and secondary offering
We advised the underwriters on the SEC-registered stock offering
Coursera $519.1 million IPO
We advised the underwriters on the IPO and NYSE listing
YUM! Brands $1.1 billion senior notes offering
We advised the underwriters on the high-yield debt offering